BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35274813)

  • 1. m
    Zheng H; Zhu M; Li W; Zhou Z; Wan X
    Liver Int; 2022 May; 42(5):1144-1157. PubMed ID: 35274813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YY1-induced DLEU1/miR-149-5p Promotes Malignant Biological Behavior of Cholangiocarcinoma through Upregulating YAP1/TEAD2/SOX2.
    Li J; Jiang X; Xu Y; Kang P; Huang P; Meng N; Wang H; Zheng W; Wang H; Wang Z; Zhong X; Cui Y
    Int J Biol Sci; 2022; 18(11):4301-4315. PubMed ID: 35864972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yin Yang 1-induced LINC00667 up-regulates pyruvate dehydrogenase kinase 1 to promote proliferation, migration and invasion of cholangiocarcinoma cells by sponging miR-200c-3p.
    Li J; Guan C; Hu Z; Liu L; Su Z; Kang P; Jiang X; Cui Y
    Hum Cell; 2021 Jan; 34(1):187-200. PubMed ID: 33040228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA myocardial infarction associated transcript promotes the proliferation of cholangiocarcinoma cells by targeting miR-551b-3p/CCND1 axis.
    Chang W; Wang Y; Li W; Geng Z
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1067-1075. PubMed ID: 32064660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA SNHG3 Facilitates the Malignant Phenotype of Cholangiocarcinoma Cells via the miR-3173-5p/ERG Axis.
    Sun ZP; Tan ZG; Peng C; Yi WM
    J Gastrointest Surg; 2022 Apr; 26(4):802-812. PubMed ID: 34647226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. lncRNA TM4SF1-AS1 predicts dismal outcomes and promotes cholangiocarcinoma progression via modulating miR-744-3p.
    Jiang H; Li W; Xue Z; Chen W; Zhao L; Song H; Hou J
    Clin Res Hepatol Gastroenterol; 2022; 46(7):101915. PubMed ID: 35346892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JUND/linc00976 promotes cholangiocarcinoma progression and metastasis, inhibits ferroptosis by regulating the miR-3202/GPX4 axis.
    Lei S; Cao W; Zeng Z; Zhang Z; Jin B; Tian Q; Wu Y; Zhang T; Li D; Hu C; Lan J; Zhang J; Chen T
    Cell Death Dis; 2022 Nov; 13(11):967. PubMed ID: 36400758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC01410 promotes cell proliferation and migration of cholangiocarcinoma through modulating miR-124-3p/SMAD5 axis.
    Jiang T; Wang C; Zhu Y; Han H
    J Gene Med; 2020 Jun; 22(6):e3162. PubMed ID: 31951299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SP1-induced HOXD-AS1 promotes malignant progression of cholangiocarcinoma by regulating miR-520c-3p/MYCN.
    Li J; Jiang X; Li Z; Huang L; Ji D; Yu L; Zhou Y; Cui Y
    Aging (Albany NY); 2020 Aug; 12(16):16304-16325. PubMed ID: 32857725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Non-coding RNA FOXD2-AS1 Promotes Proliferation, Migration, and Invasion in Cholangiocarcinoma Through Regulating miR-760/E2F3 Axis.
    Hu Z; Huang L; Wang W; Guan C; Zhao Y; Liu L; Jiang X
    Dig Dis Sci; 2022 Feb; 67(2):546-558. PubMed ID: 33570683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA LINC01061 sponges miR-612 to regulate the oncogenic role of SEMA4D in cholangiocarcinoma.
    Yu A; Zhao L; Kang Q; Chen K; Li J; Fu H; Liu J; Zhang X
    Biochem Biophys Res Commun; 2019 May; 513(2):465-471. PubMed ID: 30967271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA CDR1as Exerts Oncogenic Properties Partially through Regulating MicroRNA 641 in Cholangiocarcinoma.
    Li D; Tang Z; Gao Z; Shen P; Liu Z; Dang X
    Mol Cell Biol; 2020 Jul; 40(15):. PubMed ID: 32423991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC00844 suppresses tumor progression and predicts survival outcomes through inhibiting miR-19a-5p in cholangiocarcinoma.
    Zhang L; Jiang G; Lu J; Wang L
    Clin Transl Oncol; 2024 Feb; 26(2):414-423. PubMed ID: 37400667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway.
    Hu X; Tan Z; Yang Y; Yang P
    J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p.
    Liao G; Liu X; Wu D; Duan F; Xie X; Wen S; Li Y; Li S
    Aging (Albany NY); 2019 Jun; 11(11):3639-3649. PubMed ID: 31180332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F1-induced upregulation of long non-coding RNA LMCD1-AS1 facilitates cholangiocarcinoma cell progression by regulating miR-345-5p/COL6A3 pathway.
    Yu J; Zhang B; Zhang H; Qi Y; Wang Y; Wang W; Wang Y; Wang Y
    Biochem Biophys Res Commun; 2019 Apr; 512(2):150-155. PubMed ID: 30876691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-28-5p inhibits cholangiocarcinoma progression and predicts good prognosis of patients.
    Chen T; Wang H; Yan H
    Cell Cycle; 2022 Oct; 21(19):2079-2090. PubMed ID: 35670491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long noncoding RNA DLGAP1-AS2 facilitates cholangiocarcinoma progression via miR-505 and GALNT10.
    Liu Z; Pan L; Yan X; Duan X
    FEBS Open Bio; 2021 Feb; 11(2):413-422. PubMed ID: 33301605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Interaction Between lncRNA SNHG1 and miR-140 in Regulating Growth and Tumorigenesis via the TLR4/NF-κB Pathway in Cholangiocarcinoma.
    Li Z; Li X; Du X; Zhang H; Wu Z; Ren K; Han X
    Oncol Res; 2019 Jun; 27(6):663-672. PubMed ID: 30764893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA FALEC increases the proliferation, migration and drug resistance of cholangiocarcinoma through competitive regulation of miR-20a-5p/SHOC2 axis.
    Du H; Hou S; Zhang L; Liu C; Yu T; Zhang W
    Aging (Albany NY); 2023 May; 15(9):3759-3770. PubMed ID: 37166421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.